FDA DEVICE FACTS
Trilogy Tissue Marker
Inrad, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Intended Use and the Indications for Use are the same for the Trilogy Tissue Marker [subject device] and the INRAD, Inc. EasyMark Tissue Marker (K183503) [predicate device] with the exception of the addition of permanent visibility under MRI, x-ray and ultrasound to the Trilogy Tissue Marker [subject device].
[subject device]: The Trilogy Tissue Marker is intended for use to attach to breast tissue at the surgical site during an open surgical breast biopsy or percutaneous breast biopsy to radiographically mark the location of the biopsy procedure, and be permanently visible under MRI, x-ray and ultrasound. [predicate device]: The EasyMark Tissue Marker is intended for use to attach to soft breast tissue at the surgical site during an open surgical breast biopsy or a percutaneous breast biopsy to radiographically mark the location of the biopsy procedure.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。